Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes

[1]  Jeroen Demmers,et al.  Sin3a is essential for the genome integrity and viability of pluripotent cells , 2012, Developmental biology.

[2]  Da-Qiang Li,et al.  Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. , 2012, Cancer research.

[3]  R. Kesterson,et al.  Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis , 2012, Clinical & Experimental Metastasis.

[4]  Jong-Bok Yoon,et al.  Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex. , 2011, Biochemical and biophysical research communications.

[5]  D. Welch,et al.  Unraveling the enigmatic complexities of BRMS1‐mediated metastasis suppression , 2011, FEBS letters.

[6]  Yibin Kang,et al.  Unravelling the complexity of metastasis — molecular understanding and targeted therapies , 2011, Nature Reviews Cancer.

[7]  Georgia Sotiropoulou,et al.  DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. , 2011, Clinical chemistry.

[8]  I. Fidler,et al.  The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs , 2011, International journal of cancer.

[9]  M. Esteller,et al.  Cancer epigenetics reaches mainstream oncology , 2011, Nature Medicine.

[10]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[11]  P. Grandi,et al.  Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes , 2011, Nature Biotechnology.

[12]  M. Martinka,et al.  Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis , 2011, Oncogene.

[13]  J. Bravo,et al.  Sorting nexin 6 interacts with breast cancer metastasis suppressor‐1 and promotes transcriptional repression , 2010, Journal of cellular biochemistry.

[14]  B. Sarcevic,et al.  Cyclin-dependent Kinase-mediated Phosphorylation of RBP1 and pRb Promotes Their Dissociation to Mediate Release of the SAP30·mSin3·HDAC Transcriptional Repressor Complex* , 2010, The Journal of Biological Chemistry.

[15]  Kedar S Vaidya,et al.  Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. , 2010, Cancer research.

[16]  K. Kumamoto,et al.  Targeted Disruption of Ing2 Results in Defective Spermatogenesis and Development of Soft-Tissue Sarcomas , 2010, PloS one.

[17]  Howard Y. Chang,et al.  Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.

[18]  R. DePinho,et al.  Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis , 2010, The EMBO journal.

[19]  A. Zelent,et al.  Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells , 2010, Proceedings of the National Academy of Sciences.

[20]  O. Dovey,et al.  Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation , 2010, Proceedings of the National Academy of Sciences.

[21]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[22]  J. Workman,et al.  Deacetylase inhibitors dissociate the histone-targeting ING2 subunit from the Sin3 complex. , 2010, Chemistry & biology.

[23]  Dongquan Chen,et al.  Breast cancer metastasis suppressor 1 coordinately regulates metastasis‐associated microRNA expression , 2009, International journal of cancer.

[24]  D. Welch,et al.  Metastamir: the field of metastasis-regulatory microRNA is spreading. , 2009, Cancer research.

[25]  D. Welch,et al.  Linking metastasis suppression with metastamiR regulation , 2009, Cell cycle.

[26]  N. Crawford,et al.  The Metastasis Efficiency Modifier Ribosomal RNA Processing 1 Homolog B (RRP1B) Is a Chromatin-associated Factor* , 2009, The Journal of Biological Chemistry.

[27]  Luyang Sun,et al.  LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer , 2009, Cell.

[28]  J. Bravo,et al.  Identification of Essential Sequences for Cellular Localization in BRMS1 Metastasis Suppressor , 2009, PloS one.

[29]  Martin R. Johnson,et al.  A Shift from Nuclear to Cytoplasmic Breast Cancer Metastasis Suppressor 1 Expression Is Associated with Highly Proliferative Estrogen Receptor-Negative Breast Cancers , 2009, Tumor Biology.

[30]  G. Hortobagyi,et al.  Breast cancer metastasis: challenges and opportunities. , 2009, Cancer research.

[31]  R. Urrutia,et al.  Sin3: master scaffold and transcriptional corepressor. , 2009, Biochimica et biophysica acta.

[32]  S. Haggarty,et al.  HDAC2 negatively regulates memory formation and synaptic plasticity , 2009, Nature.

[33]  Philip Smith,et al.  Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. , 2009, Cancer letters.

[34]  Kedar S Vaidya,et al.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells. , 2009, Cancer letters.

[35]  Dan Theodorescu,et al.  Learning therapeutic lessons from metastasis suppressor proteins , 2009, Nature Reviews Cancer.

[36]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[37]  Kedar S Vaidya,et al.  Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. , 2009, Cancer research.

[38]  G. Casey,et al.  BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter , 2009, Clinical & Experimental Metastasis.

[39]  Kedar S Vaidya,et al.  Breast Cancer Metastasis Suppressor-1 Differentially Modulates Growth Factor Signaling* , 2008, Journal of Biological Chemistry.

[40]  Xiaoqi Liu,et al.  Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression. , 2008, Cancer letters.

[41]  A. Zambrano,et al.  Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[42]  S. Schokrpur,et al.  Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells , 2008, Oncogene.

[43]  V. Devita,et al.  Trials and tribulations , 2008, Nature Clinical Practice Oncology.

[44]  G. Casey,et al.  Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1 , 2008, International journal of cancer.

[45]  D. Welch,et al.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer , 2008, Clinical & Experimental Metastasis.

[46]  Kedar S Vaidya,et al.  Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[47]  Gerald C. Chu,et al.  Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation , 2008, Proceedings of the National Academy of Sciences.

[48]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.

[49]  E. Seto,et al.  The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men , 2008, Nature Reviews Molecular Cell Biology.

[50]  C. Rinker-Schaeffer,et al.  Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment , 2008, Cancer and Metastasis Reviews.

[51]  P. Steeg,et al.  Metastasis: a therapeutic target for cancer , 2008, Nature Clinical Practice Oncology.

[52]  Jinghui Zhang,et al.  Rrp1b, a New Candidate Susceptibility Gene for Breast Cancer Progression and Metastasis , 2007, PLoS genetics.

[53]  W. Wurst,et al.  Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. , 2007, Cancer research.

[54]  P. Marks,et al.  Histone Deacetylase Inhibitors: Overview and Perspectives , 2007, Molecular Cancer Research.

[55]  B. Weimer,et al.  Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression , 2007, Clinical & Experimental Metastasis.

[56]  J. Bravo,et al.  Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. , 2007, Journal of proteome research.

[57]  Xiaoxia Qi,et al.  Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. , 2007, Genes & development.

[58]  S. Eccles,et al.  Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.

[59]  I. Fidler,et al.  Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. , 2007, Endocrine reviews.

[60]  G. Casey,et al.  Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation , 2007, Molecular Cancer.

[61]  R. DePinho,et al.  Haploinsufficiency of the mSds3 chromatin regulator promotes chromosomal instability and cancer only upon complete neutralization of p53 , 2006, Oncogene.

[62]  T. Choueiri,et al.  Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients , 2006, Clinical Cancer Research.

[63]  T. Toyama,et al.  Reduced Expression of the Breast Cancer Metastasis Suppressor 1 mRNA Is Correlated with Poor Progress in Breast Cancer , 2006, Clinical Cancer Research.

[64]  A. Beaudet,et al.  Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain. , 2006, Genes & development.

[65]  D. Welch,et al.  Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. , 2006, Biochemical and biophysical research communications.

[66]  Philip Smith,et al.  Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis , 2006, Molecular and Cellular Biology.

[67]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[68]  H. Stunnenberg,et al.  Molecular characterization of Sin3 PAH-domain interactor specificity and identification of PAH partners , 2006, Nucleic acids research.

[69]  D. Welch,et al.  Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). , 2006, Cancer letters.

[70]  M. Zeremski,et al.  Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas , 2006, Oncogene.

[71]  R. Aebersold,et al.  Identification and Characterization of SAP25, a Novel Component of the mSin3 Corepressor Complex , 2006, Molecular and Cellular Biology.

[72]  Song Tan,et al.  ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. , 2006, Molecular cell.

[73]  W. Di,et al.  Suppression of human ovarian carcinoma metastasis by the metastasis‐suppressor gene, BRMS1 , 2005, International Journal of Gynecologic Cancer.

[74]  H. D. Liggitt,et al.  The mSin3A Chromatin-Modifying Complex Is Essential for Embryogenesis and T-Cell Development , 2005, Molecular and Cellular Biology.

[75]  R. DePinho,et al.  mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. , 2005, Genes & development.

[76]  G. Casey,et al.  Breast Cancer Metastasis Suppressor 1 Inhibits Gene Expression by Targeting Nuclear Factor-κB Activity , 2005 .

[77]  Joseph C. Shope,et al.  Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. , 2005, Cancer research.

[78]  R. DePinho,et al.  Cdk5/p35 Phosphorylates mSds3 and Regulates mSds3-mediated Repression of Transcription* , 2004, Journal of Biological Chemistry.

[79]  J. Qin,et al.  Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex. , 2004, Biochemical and biophysical research communications.

[80]  D. Welch,et al.  Breast cancer metastatic potential: Correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells , 2004, International journal of cancer.

[81]  J. Workman,et al.  Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription* , 2004, Journal of Biological Chemistry.

[82]  A. Protopopov,et al.  mSin3-associated protein, mSds3, is essential for pericentric heterochromatin formation and chromosome segregation in mammalian cells. , 2003, Genes & development.

[83]  D. O’Carroll,et al.  Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.

[84]  Howard H. Yang,et al.  Comparative sequence analysis in eight inbred strains of the metastasis modifier QTL candidate gene Brms1 , 2002, Mammalian Genome.

[85]  R. DePinho,et al.  Identification of Mammalian Sds3 as an Integral Component of the Sin3/Histone Deacetylase Corepressor Complex , 2002, Molecular and Cellular Biology.

[86]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[87]  A. Alessandrini,et al.  Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. , 2002, Experimental cell research.

[88]  K. Broman,et al.  Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. , 2001, Cancer research.

[89]  D. Welch,et al.  Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. , 2001, Cancer research.

[90]  D. Welch,et al.  Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. , 2000, Cancer research.

[91]  Weidong Wang,et al.  NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. , 1998, Molecular cell.

[92]  G. Robertson,et al.  A malignant melanoma tumor suppressor on human chromosome 11. , 1996, Cancer research.

[93]  B. Weissman,et al.  Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. , 1996, Cancer research.

[94]  J. Gudmundsson,et al.  Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. , 1995, British Journal of Cancer.

[95]  G. Hampton,et al.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. , 1995, Cancer research.

[96]  G. Hampton,et al.  Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. , 1994, Cancer research.

[97]  P. Devilee,et al.  Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood , 1991, International journal of cancer.

[98]  D. Stillman,et al.  Both positive and negative regulators of HO transcription are required for mother-cell-specific mating-type switching in yeast , 1987, Cell.

[99]  I. Herskowitz,et al.  Activation of the yeast HO gene by release from multiple negative controls , 1987, Cell.

[100]  品子 本田,et al.  "International Journal of Cancer"投稿論文について , 1971 .

[101]  W. E. Gye,et al.  CANCER RESEARCH , 1923, British medical journal.

[102]  L. Tanoue.  Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths , 2012 .

[103]  D. Welch,et al.  Metastasis suppressor genes at the interface between the environment and tumor cell growth. , 2011, International review of cell and molecular biology.

[104]  P. McDonel,et al.  Keeping things quiet: roles of NuRD and Sin3 co-repressor complexes during mammalian development. , 2009, The international journal of biochemistry & cell biology.

[105]  D. Welch,et al.  Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model , 2008, Clinical & Experimental Metastasis.

[106]  G. Casey,et al.  Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells , 2004, Clinical & Experimental Metastasis.

[107]  D. Theodorescu,et al.  The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines , 2004, Clinical & Experimental Metastasis.

[108]  Karl Ekwall,et al.  Sin3: a flexible regulator of global gene expression and genome stability , 2004, Current Genetics.

[109]  D. Welch,et al.  Identification and characterization of the murine ortholog (brms1) of breast‐cancer metastasis suppressor 1 (BRMS1) , 2002, International journal of cancer.